Trial: Popular cholesterol drug fails to improve heart disease "The results show the drug had "no result -- zilch. In no subgroup, in no segment, was there any added benefit" for reducing plaque, said Dr. John Kastelein, the Dutch scientist who led the study." What was the previous title? "Vytorin doesn't work." Ouch. No wonder they had to change it to something a bit softer. Where is the FTC on this?
If a dietary supplement made claims as to its ability to accomplish some healthy goal and then was proved to be worthless, you know that there would be fine$ galore. Maybe there would even be congressional hearings where Dick Durbin would decry the dangerousness and worthlessness of all dietary supplements.
Vytorin does not work.
Of course it doesn't, for it does not address the real cause of cardiovascular disease. You do not get a heart attack because you have a lack of vitamin Vytorin in your system. However, if you have a deficiency of chromium, selenium, silica and essential fats, you can be sure that you are well on your way to circulatory decline.
If you want to take a drug for heart disease, at least make it homeopathic. The most critical of heart related remedies is Crataegus, otherwise known as the Hawthorn Berry. The homeopathic snake venoms such as Vipera, Lachesis and Crotalus horridus are also very helpful to everything circulatory. Perhaps the most overlooked homeopathic remedy for vascular issues is Rhus toxicodendron, because of its affinity for uric acid (which also makes it good for musculoskeletal inflammation). While we are on the subject of cardiovascular integrity, Pulsatilla is another critical remedy that helps to purify the blood for those interested in real solutions instead of the quack medicine Vytorin.
The statin drug family is doing more to help people lose their minds under the guise of FDA approval than any other drug category. If Henry Waxman cries about my perspective on real remedies for the heart, perhaps that is evidence that his mind has already been donated to the drugs of Big Pharma. That goes double for John Dingell.
No comments:
Post a Comment